BACKGROUND: Kabuki syndrome (KS) is a rare, clinically recognisable, congenital mental retardation syndrome. The aetiology of KS remains unknown. METHODS: Four carefully selected patients with KS were screened for chromosomal imbalances using array comparative genomic hybridisation at 1 Mb resolution. RESULTS: In one patient, a 250 kb de novo microdeletion at 20p12.1 was detected, deleting exon 5 of C20orf133. The function of this gene is unknown. In situ hybridisation with the mouse orthologue of C20orf133 showed expression mainly in brain, but also in kidney, eye, inner ear, ganglia of the peripheral nervous system and lung. CONCLUSION: The de novo nature of the deletion, the expression data and the fact that C20orf133 carries a macro domain, suggesting a role for the gene in chromatin biology, make the gene a likely candidate to cause the phenotype in this patient with KS. Both the finding of different of chromosomal rearrangements in patients with KS features and the absence of C20orf133 mutations in 19 additional patients with KS suggest that KS is genetically heterogeneous.
BACKGROUND:Kabuki syndrome (KS) is a rare, clinically recognisable, congenital mental retardation syndrome. The aetiology of KS remains unknown. METHODS: Four carefully selected patients with KS were screened for chromosomal imbalances using array comparative genomic hybridisation at 1 Mb resolution. RESULTS: In one patient, a 250 kb de novo microdeletion at 20p12.1 was detected, deleting exon 5 of C20orf133. The function of this gene is unknown. In situ hybridisation with the mouse orthologue of C20orf133 showed expression mainly in brain, but also in kidney, eye, inner ear, ganglia of the peripheral nervous system and lung. CONCLUSION: The de novo nature of the deletion, the expression data and the fact that C20orf133 carries a macro domain, suggesting a role for the gene in chromatin biology, make the gene a likely candidate to cause the phenotype in this patient with KS. Both the finding of different of chromosomal rearrangements in patients with KS features and the absence of C20orf133 mutations in 19 additional patients with KS suggest that KS is genetically heterogeneous.
Authors: John J M Engelen; Wim H Loneus; Gerrie Vaes-Peeters; Constance T R M Schrander-Stumpel Journal: Am J Med Genet A Date: 2005-01-30 Impact factor: 2.802
Authors: J D Hoffman; Y Zhang; J Greshock; K L Ciprero; B S Emanuel; E H Zackai; B L Weber; J E Ming Journal: J Med Genet Date: 2005-01 Impact factor: 6.318
Authors: E Galán-Gómez; J J Cardesa-García; F M Campo-Sampedro; C Salamanca-Maesso; M L Martínez-Frías; J L Frías Journal: Am J Med Genet Date: 1995-11-20
Authors: Dawei Chen; Melanie Vollmar; Marianna N Rossi; Claire Phillips; Rolf Kraehenbuehl; Dea Slade; Pawan V Mehrotra; Frank von Delft; Susan K Crosthwaite; Opher Gileadi; John M Denu; Ivan Ahel Journal: J Biol Chem Date: 2011-01-21 Impact factor: 5.157
Authors: W Edward C Bradley; John V Raelson; Daniel Y Dubois; Eric Godin; Hélène Fournier; Charles Privé; René Allard; Vadym Pinchuk; Micheline Lapalme; René J A Paulussen; Abdelmajid Belouchi Journal: PLoS One Date: 2010-02-25 Impact factor: 3.240
Authors: Avigail Agam; Binnaz Yalcin; Amarjit Bhomra; Matthew Cubin; Caleb Webber; Christopher Holmes; Jonathan Flint; Richard Mott Journal: PLoS One Date: 2010-09-21 Impact factor: 3.240